Comparison of Coronary Lithoplasty and Rotablation
1 other identifier
interventional
70
1 country
1
Brief Summary
This study compares a new method of treating severely calcified coronary lesions, the intracoronary lithoplasty, with the current gold standard, the rotablation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable coronary-artery-disease
Started Jun 2019
Typical duration for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 28, 2019
CompletedFirst Submitted
Initial submission to the registry
July 22, 2019
CompletedFirst Posted
Study publicly available on registry
August 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2022
CompletedDecember 1, 2023
November 1, 2023
2 years
July 22, 2019
November 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Minimal Stent Area (End of the Procedure)
0 days
Secondary Outcomes (7)
Minimal/Mean/Maximal Stent Diameter
0 days
Minimal/Mean/Maximal Lumen area
0 days
Minimal/Mean/Maximal Lumen diameter
0 days
Mean/Maximal Stent area
0 days
Incidence of target lesion failure
0 months; 1 month; 6 months
- +2 more secondary outcomes
Study Arms (2)
Rotablation
ACTIVE COMPARATORCoronary Lithoplasty
EXPERIMENTALInterventions
Percutaneous Coronary Intervention using Lithoplasty
Eligibility Criteria
You may qualify if:
- Age\>18 yrs
- Stable coronary heart disease or acute coronary syndromes
- Single or multi vessel disease. Vessel is defined as, left anterior descending, left circumflex, and right coronary arteries. Any branch within the vessel is considered part of the vessel.
- Written informed consent was obtained before the procedure
- Severely calcified coronary lesion with indication for rotablation
You may not qualify if:
- Known renal insufficiency (serum creatinine clearance \<30ml/min/1.73m² or receiving dialysis)
- Known allergy against protocol-required medications including ASS, prasugrel, ticagrelor, clopidogrel, heparin. History of bleeding diathesis or known coagulopathy
- Cardiogenic shock
- Lesion length \> 32mm
- Bifurcation lesions requiring 2-Stent-Strategies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Giessen
Giessen, 35392, Germany
Related Publications (1)
Blachutzik F, Meier S, Weissner M, Schlattner S, Gori T, Ullrich-Daub H, Gaede L, Achenbach S, Mollmann H, Chitic B, Aksoy A, Nickenig G, Weferling M, Dorr O, Boeder N, Bayer M, Elsasser A, Hamm C, Nef H; ROTA.Shock Investigators. Comparison of Coronary Intravascular Lithotripsy and Rotational Atherectomy in the Modification of Severely Calcified Stenoses. Am J Cardiol. 2023 Jun 15;197:93-100. doi: 10.1016/j.amjcard.2023.02.028. Epub 2023 Apr 2.
PMID: 37012181DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Florian Blachutzik, Dr.
University of Giessen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2019
First Posted
August 6, 2019
Study Start
June 28, 2019
Primary Completion
June 28, 2021
Study Completion
June 28, 2022
Last Updated
December 1, 2023
Record last verified: 2023-11